-
2
-
-
79958830450
-
Fibrosis in endstage human heart failure: severe changes in collagen metabolism and mmp/timp profiles
-
Polyakova V, Loeffler I, Hein S, etal. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and mmp/timp profiles. Int J Cardiol. 2011; 151: 18-33.
-
(2011)
Int J Cardiol
, vol.151
, pp. 18-33
-
-
Polyakova, V.1
Loeffler, I.2
Hein, S.3
-
3
-
-
70350575289
-
Il-17 induces myocardial fibrosis and enhances rankl/opg and mmp/timp signaling in isoproterenol-induced heart failure
-
Feng W, Li W, Liu W, etal. Il-17 induces myocardial fibrosis and enhances rankl/opg and mmp/timp signaling in isoproterenol-induced heart failure. Exp Mol Pathol. 2009; 87: 212-8.
-
(2009)
Exp Mol Pathol
, vol.87
, pp. 212-218
-
-
Feng, W.1
Li, W.2
Liu, W.3
-
4
-
-
77949768174
-
Tgf-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease
-
Xiao H, Lei H, Qin S, etal. Tgf-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease. Clin Cardiol. 2010; 33: 149-56.
-
(2010)
Clin Cardiol
, vol.33
, pp. 149-156
-
-
Xiao, H.1
Lei, H.2
Qin, S.3
-
5
-
-
27844536950
-
Differential role of tgf-beta1/bfgf and et-1 in graft fibrosis in heart failure patients
-
Aharinejad S, Krenn K, Paulus P, etal. Differential role of tgf-beta1/bfgf and et-1 in graft fibrosis in heart failure patients. Am J Transplant. 2005; 5: 2185-92.
-
(2005)
Am J Transplant
, vol.5
, pp. 2185-2192
-
-
Aharinejad, S.1
Krenn, K.2
Paulus, P.3
-
6
-
-
0033745462
-
Ctgf expression is induced by tgf- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis
-
Chen MM, Lam A, Abraham JA, etal. Ctgf expression is induced by tgf- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol. 2000; 32: 1805-19.
-
(2000)
J Mol Cell Cardiol
, vol.32
, pp. 1805-1819
-
-
Chen, M.M.1
Lam, A.2
Abraham, J.A.3
-
7
-
-
0037083875
-
Ovarian hormones induce tgf-beta(3) and fibronectin mrnas but exhibit a disparate action on cardiac fibroblast proliferation
-
Mercier I, Colombo F, Mader S, etal. Ovarian hormones induce tgf-beta(3) and fibronectin mrnas but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovasc Res. 2002; 53: 728-39.
-
(2002)
Cardiovasc Res
, vol.53
, pp. 728-739
-
-
Mercier, I.1
Colombo, F.2
Mader, S.3
-
8
-
-
78651104122
-
Valsartan decreases tgf-beta1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats
-
Subeq YM, Ke CY, Lin NT, etal. Valsartan decreases tgf-beta1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats. Cytokine. 2011; 53: 223-30.
-
(2011)
Cytokine
, vol.53
, pp. 223-230
-
-
Subeq, Y.M.1
Ke, C.Y.2
Lin, N.T.3
-
9
-
-
78649888294
-
Fosinopril and valsartan intervention in gene expression of klotho, mmp-9, timp-1, and pai-1 in the kidney of spontaneously hypertensive rats
-
Cheng X, Zhou Q, Lin S, etal. Fosinopril and valsartan intervention in gene expression of klotho, mmp-9, timp-1, and pai-1 in the kidney of spontaneously hypertensive rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010; 35: 1048-56.
-
(2010)
Zhong Nan Da Xue Xue Bao Yi Xue Ban
, vol.35
, pp. 1048-1056
-
-
Cheng, X.1
Zhou, Q.2
Lin, S.3
-
10
-
-
84857634811
-
Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: Nagoya heart study
-
Muramatsu T, Matsushita K, Yamashita K, etal. Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: Nagoya heart study. Hypertension. 2012; 59: 580-6.
-
(2012)
Hypertension
, vol.59
, pp. 580-586
-
-
Muramatsu, T.1
Matsushita, K.2
Yamashita, K.3
-
11
-
-
34247379373
-
Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
-
Mochizuki S, Dahlof B, Shimizu M, etal. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet. 2007; 369: 1431-9.
-
(2007)
Lancet
, vol.369
, pp. 1431-1439
-
-
Mochizuki, S.1
Dahlof, B.2
Shimizu, M.3
-
12
-
-
19444374007
-
Valsartan reduces morbidity in people with heart failure receiving a low dose of ace inhibitor and no beta-blocker. Commentary
-
Pierard LA. Valsartan reduces morbidity in people with heart failure receiving a low dose of ace inhibitor and no beta-blocker. Commentary. Evid Based Cardiovasc Med. 2005; 9: 115-6.
-
(2005)
Evid Based Cardiovasc Med
, vol.9
, pp. 115-116
-
-
Pierard, L.A.1
-
13
-
-
58149382068
-
Long-term treatment with valsartan improved cyclic variation of the myocardial integral backscatter signal and diastolic dysfunction in hypertensive patients: the echocardiographic assessment
-
Mizuta Y, Kai H, Mizoguchi M, etal. Long-term treatment with valsartan improved cyclic variation of the myocardial integral backscatter signal and diastolic dysfunction in hypertensive patients: the echocardiographic assessment. Hypertens Res. 2008; 31: 1835-42.
-
(2008)
Hypertens Res
, vol.31
, pp. 1835-1842
-
-
Mizuta, Y.1
Kai, H.2
Mizoguchi, M.3
-
14
-
-
35048904208
-
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
-
Bissessor N, White H. Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction. Vasc Health Risk Manag. 2007; 3: 425-30.
-
(2007)
Vasc Health Risk Manag
, vol.3
, pp. 425-430
-
-
Bissessor, N.1
White, H.2
-
15
-
-
0037061910
-
Valsartan in chronic heart failure
-
Cayley WE Jr. Valsartan in chronic heart failure. N Engl J Med. 2002; 346: 1173-4.
-
(2002)
N Engl J Med
, vol.346
, pp. 1173-1174
-
-
Cayley Jr, W.E.1
-
16
-
-
84864085352
-
Valsartan inhibited hif-1alpha pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats
-
Tang L, Yi R, Yang B, etal. Valsartan inhibited hif-1alpha pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats. Diabetes Res Clin Pract. 2012; 97: 125-31.
-
(2012)
Diabetes Res Clin Pract
, vol.97
, pp. 125-131
-
-
Tang, L.1
Yi, R.2
Yang, B.3
-
17
-
-
84901457818
-
Smooth muscle cell-specific hif-1alpha deficiency suppresses angiotensin II-induced vascular remodelling in mice
-
Imanishi M, Tomita S, Ishizawa K, etal. Smooth muscle cell-specific hif-1alpha deficiency suppresses angiotensin II-induced vascular remodelling in mice. Cardiovasc Res. 2014; 102: 460-8.
-
(2014)
Cardiovasc Res
, vol.102
, pp. 460-468
-
-
Imanishi, M.1
Tomita, S.2
Ishizawa, K.3
-
18
-
-
77956364637
-
Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes
-
Chiu CZ, Wang BW, Chung TH, etal. Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes. Clin Sci. 2010; 119: 273-82.
-
(2010)
Clin Sci
, vol.119
, pp. 273-282
-
-
Chiu, C.Z.1
Wang, B.W.2
Chung, T.H.3
-
19
-
-
34250870604
-
Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death
-
Potier E, Ferreira E, Meunier A, etal. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng. 2007; 13: 1325-31.
-
(2007)
Tissue Eng
, vol.13
, pp. 1325-1331
-
-
Potier, E.1
Ferreira, E.2
Meunier, A.3
-
20
-
-
77955709587
-
Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel
-
Wang H, Zhang X, Li Y, etal. Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel. J Heart Lung Transplant. 2010; 29: 881-7.
-
(2010)
J Heart Lung Transplant
, vol.29
, pp. 881-887
-
-
Wang, H.1
Zhang, X.2
Li, Y.3
-
21
-
-
84862784201
-
The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment
-
Liu Z, Wang H, Wang Y, etal. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials. 2012; 33: 3093-106.
-
(2012)
Biomaterials
, vol.33
, pp. 3093-3106
-
-
Liu, Z.1
Wang, H.2
Wang, Y.3
-
22
-
-
77950809834
-
Both the transplantation of somatic cell nuclear transfer- and fertilization-derived mouse embryonic stem cells with temperature-responsive chitosan hydrogel improve myocardial performance in infarcted rat hearts
-
Lu S, Wang H, Lu W, etal. Both the transplantation of somatic cell nuclear transfer- and fertilization-derived mouse embryonic stem cells with temperature-responsive chitosan hydrogel improve myocardial performance in infarcted rat hearts. Tissue Eng Part A. 2010; 16: 1303-15.
-
(2010)
Tissue Eng Part A
, vol.16
, pp. 1303-1315
-
-
Lu, S.1
Wang, H.2
Lu, W.3
-
23
-
-
84863702343
-
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
-
Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012; 18: 1028-40.
-
(2012)
Nat Med
, vol.18
, pp. 1028-1040
-
-
Wynn, T.A.1
Ramalingam, T.R.2
-
24
-
-
0037899249
-
The myofibroblast in wound healing and fibrocontractive diseases
-
Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003; 200: 500-3.
-
(2003)
J Pathol
, vol.200
, pp. 500-503
-
-
Gabbiani, G.1
-
26
-
-
33745843718
-
Effects of perindopril and valsartan on expression of transforming growth factor-beta-smads in experimental hepatic fibrosis in rats
-
Xu W, Song S, Huang Y, etal. Effects of perindopril and valsartan on expression of transforming growth factor-beta-smads in experimental hepatic fibrosis in rats. J Gastroenterol Hepatol. 2006; 21: 1250-6.
-
(2006)
J Gastroenterol Hepatol
, vol.21
, pp. 1250-1256
-
-
Xu, W.1
Song, S.2
Huang, Y.3
-
27
-
-
22144453935
-
Angiotensin II type 1 receptor blocker inhibits pulmonary injury
-
Mancini GB, Khalil N. Angiotensin II type 1 receptor blocker inhibits pulmonary injury. Clin Invest Med. 2005; 28: 118-26.
-
(2005)
Clin Invest Med
, vol.28
, pp. 118-126
-
-
Mancini, G.B.1
Khalil, N.2
-
28
-
-
34447326418
-
Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats
-
Yoshida K, Kobayashi N, Ohno T, etal. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats. J Hypertens. 2007; 25: 1633-42.
-
(2007)
J Hypertens
, vol.25
, pp. 1633-1642
-
-
Yoshida, K.1
Kobayashi, N.2
Ohno, T.3
-
29
-
-
0030924446
-
Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target?
-
Noble NA, Border WA. Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol. 1997; 17: 455-66.
-
(1997)
Semin Nephrol
, vol.17
, pp. 455-466
-
-
Noble, N.A.1
Border, W.A.2
-
30
-
-
0141792887
-
Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients
-
el-Agroudy AE, Hassan NA, Foda MA, etal. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients. Am J Nephrol. 2003; 23: 300-6.
-
(2003)
Am J Nephrol
, vol.23
, pp. 300-306
-
-
el-Agroudy, A.E.1
Hassan, N.A.2
Foda, M.A.3
-
31
-
-
84864320125
-
Angiotensin II increases CTGF expression via mapks/tgf-beta1/traf6 pathway in atrial fibroblasts
-
Gu J, Liu X, Wang QX, etal. Angiotensin II increases CTGF expression via mapks/tgf-beta1/traf6 pathway in atrial fibroblasts. Exp Cell Res. 2012; 318: 2105-15.
-
(2012)
Exp Cell Res
, vol.318
, pp. 2105-2115
-
-
Gu, J.1
Liu, X.2
Wang, Q.X.3
-
32
-
-
34247473874
-
[Activation of transforming growth factor-beta1/smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats]
-
Miao Y, Zhang W, Zhong M, etal. [Activation of transforming growth factor-beta1/smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats]. Zhonghua Yi Xue Za Zhi. 2007; 87: 366-70.
-
(2007)
Zhonghua Yi Xue Za Zhi
, vol.87
, pp. 366-370
-
-
Miao, Y.1
Zhang, W.2
Zhong, M.3
-
33
-
-
84860335047
-
Rsume is implicated in hif-1-induced vegf-a production in pituitary tumour cells
-
Shan B, Gerez J, Haedo M, etal. Rsume is implicated in hif-1-induced vegf-a production in pituitary tumour cells. Endocr Relat Cancer. 2012; 19: 13-27.
-
(2012)
Endocr Relat Cancer
, vol.19
, pp. 13-27
-
-
Shan, B.1
Gerez, J.2
Haedo, M.3
-
34
-
-
84911032637
-
Activation of the AT1R/HIF-1 α/ACE axis mediates angiotensin II-induced VEGF synthesis in mesenchymal stem cells
-
Liu C, Zhang JW, Hu L, etal. Activation of the AT1R/HIF-1 α/ACE axis mediates angiotensin II-induced VEGF synthesis in mesenchymal stem cells. Biomed Res Int. 2014; 2014: 627380.
-
(2014)
Biomed Res Int
, vol.2014
, pp. 627380
-
-
Liu, C.1
Zhang, J.W.2
Hu, L.3
-
35
-
-
79959968571
-
Molecular mechanism of hif-1-independent vegf expression in a hepatocellular carcinoma cell line
-
Choi SB, Park JB, Song TJ, etal. Molecular mechanism of hif-1-independent vegf expression in a hepatocellular carcinoma cell line. Int J Mol Med. 2011; 28: 449-54.
-
(2011)
Int J Mol Med
, vol.28
, pp. 449-454
-
-
Choi, S.B.1
Park, J.B.2
Song, T.J.3
-
36
-
-
84864699868
-
Decreased vegf expression and microvascular density, but increased hif-1 and 2alpha accumulation and epo expression in chronic moderate hyperoxia in the mouse brain
-
Benderro GF, Sun X, Kuang Y, etal. Decreased vegf expression and microvascular density, but increased hif-1 and 2alpha accumulation and epo expression in chronic moderate hyperoxia in the mouse brain. Brain Res. 2012; 1471: 46-55.
-
(2012)
Brain Res
, vol.1471
, pp. 46-55
-
-
Benderro, G.F.1
Sun, X.2
Kuang, Y.3
|